Evidence map›Paper›PMID 35956174›Full record

ReviewJournal of clinical medicine2022

Oocyte Cryopreservation in Patients with Endometriosis: Current Knowledge and Number Needed to Treat.

Laurie Henry, Julie Vervier, Astrid Boucher, Géraldine Brichant, Olivier Gaspard, Soraya Labied, Carine Munaut, Stéphanie Ravet, Michelle Nisolle

Abstract readReview
In one paragraph

Review in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Clinical Utilities of Anti-Müllerian Hormone.Journal of clinical medicine · 2022
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Laurie HenryCenter for Reproductive Medicine, University of Liège, Boulevard du 12ème de Ligne 1, 4000 Liege, Belgium.
Julie VervierObstetrics and Gynecology Department, University of Liège, Boulevard du 12ème de Ligne 1, 4000 Liege, Belgium.
Astrid BoucherCenter for Reproductive Medicine, University of Liège, Boulevard du 12ème de Ligne 1, 4000 Liege, Belgium.
Géraldine BrichantObstetrics and Gynecology Department, University of Liège, Boulevard du 12ème de Ligne 1, 4000 Liege, Belgium.ORCID 0000-0002-3233-4772
Olivier GaspardCenter for Reproductive Medicine, University of Liège, Boulevard du 12ème de Ligne 1, 4000 Liege, Belgium.
Soraya LabiedCenter for Reproductive Medicine, University of Liège, Boulevard du 12ème de Ligne 1, 4000 Liege, Belgium.
Carine MunautLaboratory of Tumor and Development Biology, Giga-Cancer, University of Liège, 4000 Liege, Belgium.ORCID 0000-0003-4952-9637
Stéphanie RavetCenter for Reproductive Medicine, University of Liège, Boulevard du 12ème de Ligne 1, 4000 Liege, Belgium.
Michelle NisolleObstetrics and Gynecology Department, University of Liège, Boulevard du 12ème de Ligne 1, 4000 Liege, Belgium.ORCID 0000-0002-7070-7146

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rise of oocytes cryopreservation (OOC) in assisted reproductive techniques allows fertility preservation (FP) in an increasing number of indications. Endometriosis, a highly prevalent disease, potentially impairing ovarian reserve, seems, therefore, an interesting indication for it. The purpose of this study is to summarize the available evidence concerning FP by OOC in women with endometriosis and to calculate the number needed to treat (NNT). In total, 272 articles related to this topic were identified in PubMed. Eight studies were eligible for the review. In order to shed some light, a SWOT analysis was performed and the argument pros and cons were developed. The NNT calculated of OOC was 16, meaning that 16 women need to perform an OOC for one of them to have a child that she would not have had without this technique. In conclusion, OOC must be discussed with patients who suffer from endometriosis since it is an effective technique of FP, which can allow these patients to succeed a pregnancy that they otherwise would not have achieved. Nevertheless, it should not be performed in all patients as there is still a lack of robust socio-economic and risk-benefit data.

Indexed as

endometriosisfertility preservationoocyte vitrification

Identifiers

PMID35956174
PMCPMC9369629

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.